Surgical management of metastatic melanoma in the era of targeted systemic therapies

D. Peter O'Leary; Kevin G. Byrnes; Derek G. Power; H. Paul Redmond

doi:10.1097/CMR.0000000000000128

Surgical management of metastatic melanoma in the era of targeted systemic therapies

D. Peter O'Leary
, Kevin G. Byrnes
, Derek G. Power
, H. Paul Redmond

School of Medicine

University College Cork

Research output: Contribution to journal › Review article › peer-review

Abstract

Treatment strategies for metastatic melanoma have changed markedly in recent times due to the advent of targeted systemic therapies. In addition to these developments, surgery remains a useful adjunct that can confer survival benefits in selected patients. In this review, we examine the current literature to highlight the role of surgical intervention in metastatic melanoma in the era of targeted systemic therapies.

Original language	English
Pages (from-to)	1-8
Number of pages	8
Journal	Melanoma Research
Volume	25
Issue number	1
DOIs	https://doi.org/10.1097/CMR.0000000000000128
Publication status	Published - 3 Feb 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Melanoma
surgery
systemic therapy

Access to Document

10.1097/CMR.0000000000000128

Cite this

@article{4c3aba2852dc4115b2bf9dd5df8dc425,

title = "Surgical management of metastatic melanoma in the era of targeted systemic therapies",

abstract = "Treatment strategies for metastatic melanoma have changed markedly in recent times due to the advent of targeted systemic therapies. In addition to these developments, surgery remains a useful adjunct that can confer survival benefits in selected patients. In this review, we examine the current literature to highlight the role of surgical intervention in metastatic melanoma in the era of targeted systemic therapies.",

keywords = "Melanoma, surgery, systemic therapy",

author = "\{Peter O'Leary\}, D. and Byrnes, \{Kevin G.\} and Power, \{Derek G.\} and \{Paul Redmond\}, H.",

year = "2015",

month = feb,

day = "3",

doi = "10.1097/CMR.0000000000000128",

language = "English",

volume = "25",

pages = "1--8",

journal = "Melanoma Research",

issn = "0960-8931",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Surgical management of metastatic melanoma in the era of targeted systemic therapies

AU - Peter O'Leary, D.

AU - Byrnes, Kevin G.

AU - Power, Derek G.

AU - Paul Redmond, H.

PY - 2015/2/3

Y1 - 2015/2/3

N2 - Treatment strategies for metastatic melanoma have changed markedly in recent times due to the advent of targeted systemic therapies. In addition to these developments, surgery remains a useful adjunct that can confer survival benefits in selected patients. In this review, we examine the current literature to highlight the role of surgical intervention in metastatic melanoma in the era of targeted systemic therapies.

AB - Treatment strategies for metastatic melanoma have changed markedly in recent times due to the advent of targeted systemic therapies. In addition to these developments, surgery remains a useful adjunct that can confer survival benefits in selected patients. In this review, we examine the current literature to highlight the role of surgical intervention in metastatic melanoma in the era of targeted systemic therapies.

KW - Melanoma

KW - surgery

KW - systemic therapy

UR - https://www.scopus.com/pages/publications/84920183300

U2 - 10.1097/CMR.0000000000000128

DO - 10.1097/CMR.0000000000000128

M3 - Review article

C2 - 25532830

AN - SCOPUS:84920183300

SN - 0960-8931

VL - 25

SP - 1

EP - 8

JO - Melanoma Research

JF - Melanoma Research

IS - 1

ER -

Surgical management of metastatic melanoma in the era of targeted systemic therapies

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this